Group Intervention Study for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

Implementation and Feasibility Study of Group Intervention for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

Dysarthria is a common problem in Pakistan. therefore the current study aims to translate the dysarthria communication tools into urdu language for better understanding the population and the problem

Study Overview

• Status: Completed
• Conditions: Dysarthria As Late Effect of Stroke
• Intervention / Treatment: Other: Regular speech therapy; Other: Group intervention

Detailed Description

Dysarthria is the inefficiency or restricted capability to form intelligible speech because of the inability of motor control on the speech structures. There are many therapeutic approaches in Pakistan that are in use for the patients with dysarthria following stroke. One of them is one to one intervention which may include one dysarthria client along with the speech therapist. The therapist delivers step by step instructions to the client. The essential assessments are being held to initiate the treatment. The application of this intervention approach leaves some drawbacks, such as, the patients find it difficult to relate and adapt to the treatment offered. Generalization also seems to be complicated. The patients express a lack in motivation and support. The other mode of approach is group intervention, in which multiple dysarthria clients along with their caregivers & speech therapist are included. In the later one, there are greater chances of recovery for patients as they get peer support and build confidence through newfound friends, peer communication with realistic social setting, learning through teaching, increased awareness of skills and it is time constraints. The culture of practicing group sessions with dysarthria patients is lacked in Pakistan, which intends to meet and compensate for all the drawbacks and lacks of one on one intervention. By including the Dysarthria patients, therapist and the caregivers in the group intervention, there're greater chances of reduced anxiety for both patients & caregivers regarding disorder & its recovery.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Lahore, Punjab, Pakistan, 54000
      • Sheikh Zayed medical Complex

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 36 years to 66 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. 40 to 70 years age ranges
2. History of dysarthria previous six monthes
3. Primary level of education
4. Functional hearing and visual ablities -

Exclusion Criteria:

1. Patient with age below 40 to 70
2. Patients with diagnosis severe psychological illness
3. Patient with developmental dysarthria
4. Patient who come alone without any attendent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Regular speech therapy; Regular speech therapy will be provided to the controlled group.	Other: Regular speech therapy; Regular speech therapy will be provided to the controlled group.Regular speech therapy is one to one speech therapy session,conducted twice a week for the duration of eight weeks.This intervention is implemented to patients with dysarthria following stroke in a format of one patient and one therapist per session.
Other: Group intervention; Group intervention will be provided to the experimental group.	Other: Group intervention; Group intervention programme designed for stroke survivors with dysarthria and their carers. The programme was eight weeks long, with weekly two sessions, each session lasting for two hours, lead by speech language therapist and was comprised of activities which addressed participants education about their dysarthria and stroke. The role of family , peer and professional was to provide support and communication practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Roberston Dysarthria Profile.	Roberston Dysarthria Profile take responses on 5 point likert scale where 1 for worst and 5 for better outcome.	6 months
efficacy of group intervention for Patients With Dysarthria will be assessed by translated version of Communication Effectivness Measure	Communication Effectivness Measure is seven point scale arranging from 1 to 7 where 1 for worst outcome and 7 for better outcome.	6 months
Efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Communicative Participation Item Bank.	Communicative Participation Item Bank is four point scale arranging from 0 to 3 where 0 for better communication participation and 3 for worst communication participation.	6 months
Efficacy of group intervention for Patients With Dysarthria will be assessed by Gernal Health Questionnaire	Gernal Health Questionnaire is four point scale in which responses 1 means better and 4 for worst condition	6 months
Efficacy of group intervention for Patients With Dysarthria will be assessed by Speech Intelligiblity Test	Speech Intelligiblity Test is three point scale where 2 stands for correct utterances and 0 shows wrong production of sounds.	6 months

Collaborators and Investigators

• Sponsor: Isra University
• Investigators: Principal Investigator: Saima M Ali, PhD, Isra University, Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2020
• Primary Completion (Actual): November 15, 2021
• Study Completion (Actual): July 12, 2024

Study Registration Dates

• First Submitted: March 14, 2020
• First Submitted That Met QC Criteria: June 8, 2020
• First Posted (Actual): June 11, 2020

Study Record Updates

• Last Update Posted (Actual): October 15, 2024
• Last Update Submitted That Met QC Criteria: October 10, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Keywords: Stroke; Intervention; Dysarthia
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Neurobehavioral Manifestations; Language Disorders; Communication Disorders; Speech Disorders; Articulation Disorders; Stroke; Dysarthria
• Other Study ID Numbers: 201/2020

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No